A clinically significant anti-HLA-A2 detectable by extended incubation cytotoxicity and flow cytometric techniques but not by a standard NIH lymphocytotoxicity test
By: S.F. Garner, J. Petrochilos, C.J. Brown, S. Cavanna, I. Chanarin and C. Navarrete
Paid access
|Nov 2020Authors
S.F. Garner
Transfusion Medicine Scientist, Division of Transfusion Medicine, University of Cambridge, Cambridge, UK
J. Petrochilos
Aglaia Kyriakou, Children’s Hospital, Athens, Greece
C.J. Brown
NBS, London, UK
S. Cavanna
NBS, London, UK
I. Chanarin
The Clementine Churchill Hospital, London, UK
C. Navarrete
London and South East Zone, North London Centre, London, UK
DOI: https://doi.org/10.21307/immunohematology-2019-703 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 49 - 53
Published on: Nov 9, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2020 S.F. Garner, J. Petrochilos, C.J. Brown, S. Cavanna, I. Chanarin, C. Navarrete, published by American National Red Cross
This work is licensed under the Creative Commons License.